CANDACE FLOURNOY: Open Payments
NPI 1780234690 · LAWTON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 21 payments from 7 companies in 2025. Trend: 2023 $450 · 2024 $413 · 2025 $463
Food & beverage: $407Education: $56
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $154 |
| GENZYME CORPORATION | 5 | $108 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $99 |
| Phathom Pharmaceuticals, Inc. | 3 | $43 |
| Optinose US, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| REVANCE THERAPEUTICS, INC. | 1 | $14 |
Products named: DUPIXENT, NEFFY, VOQUEZNA, Xhance, NUCALA, DAXXIFY.
Industry payments across OK — which companies pay providers there.
